Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)
Conditions
- Atrial Fibrillation
- Recurrent Venous Thromboembolism
Interventions
- DRUG: dabigatran, rivaroxaban, apixaban or edoxaban
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborators